Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Diagnosis and management of chronic graft-versus-host disease. Br J Haematol 2012 Jul;158(1):46-61

Date

04/27/2012

Pubmed ID

22533811

DOI

10.1111/j.1365-2141.2012.09128.x

Scopus ID

2-s2.0-84862263770 (requires institutional sign-in at Scopus site)   149 Citations

Abstract

A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD). This guideline includes recommendations for the diagnosis and staging of chronic GvHD as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be the effective control of GvHD while minimizing the risk of toxicity and relapse.

Author List

Dignan FL, Amrolia P, Clark A, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation

Author

Bronwen E. Shaw MBChB, PhD Center Director, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Bone Marrow Transplantation
Chronic Disease
Disease Management
Graft vs Host Disease
Humans
Stem Cell Transplantation